These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Yin YH; Wang F; Pan YH; Wang Y; Wang Y; Luo QZ; Jiang JY Am J Med Sci; 2009 Feb; 337(2):123-5. PubMed ID: 19214028 [TBL] [Abstract][Full Text] [Related]
24. Dangers of outpatient nimodipine use after spontaneous subarachnoid hemorrhage in accordance with the Comprehensive Stroke Center guidelines. Chen CJ; Turnage C; Sokolowski JD; Kumar JS; Kalani MY; Park MS J Clin Neurosci; 2018 Jun; 52():151-152. PubMed ID: 29656002 [TBL] [Abstract][Full Text] [Related]
25. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Ditz C; Matone MV; Schwachenwald B; Küchler J Neurosurg Rev; 2024 Jan; 47(1):37. PubMed ID: 38191859 [TBL] [Abstract][Full Text] [Related]
26. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340 [TBL] [Abstract][Full Text] [Related]
27. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation. Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157 [TBL] [Abstract][Full Text] [Related]
28. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage. Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL; Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631 [TBL] [Abstract][Full Text] [Related]
29. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]). Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL; Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607 [TBL] [Abstract][Full Text] [Related]
31. Clinical experience of selective intra-arterial nimodipine treatment for cerebral vasospasm following subarachnoid hemorrhage. Biondi A; Le Jean L; Puybasset L AJNR Am J Neuroradiol; 2006 Mar; 27(3):474; author reply 474. PubMed ID: 16551980 [No Abstract] [Full Text] [Related]
32. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Zhang Y; Xu B; Zhao K; Wang R; Mao Y; Xu B; Zhang X; Neurol Med Chir (Tokyo); 2011; 51(10):679-83. PubMed ID: 22027241 [TBL] [Abstract][Full Text] [Related]
33. In brief: nimodipine oral solution (Nymalize). Med Lett Drugs Ther; 2013 Aug; 55(1423):68. PubMed ID: 23959389 [No Abstract] [Full Text] [Related]
34. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257 [TBL] [Abstract][Full Text] [Related]
36. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage? Goel R; Aggarwal A; Salunke P; Kumar A; Chhabra R Br J Neurosurg; 2016 Aug; 30(4):407-10. PubMed ID: 26999260 [TBL] [Abstract][Full Text] [Related]
37. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. Ehtisham A; Taylor S; Bayless L; Samuels OB; Klein MW; Janzen JM South Med J; 2009 Feb; 102(2):150-3. PubMed ID: 19139684 [TBL] [Abstract][Full Text] [Related]
38. Hypoxemia associated with nimodipine in a patient with an aneurysmal subarachnoid hemorrhage. Baker M; Bastin MT; Cook AM; Fraser J; Hessel E Am J Health Syst Pharm; 2015 Jan; 72(1):39-43. PubMed ID: 25511836 [TBL] [Abstract][Full Text] [Related]
39. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation. Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152 [TBL] [Abstract][Full Text] [Related]
40. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. van den Bergh WM; Mees SM; Rinkel GJ Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]